Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prema S Rao

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Biochemical and Biophysical Research Communications|July 16, 2003
Protein kinase C mu is down-regulated in androgen-independent prostate cancerMeena Jaggi, Prema S Rao, David J Smith, et al.
Biochemical and Biophysical Research Communications|October 11, 2003
Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancerPrema S Rao, Meena Jaggi, David J Smith, et al.
International Journal of Oncology|November 8, 2006
RNF2 interacts with the linker region of the human P-glycoproteinPrema S Rao, Kavita B Mallya, Kalkunte S Srivenugopal, et al.
Proteomics|May 1, 2009
RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathwaysPrema S Rao, Arun Satelli, Sheng Zhang, et al.
Oncology Reports|February 22, 2008
Varied expression and localization of multiple galectins in different cancer cell linesArun Satelli, Prema S Rao, Prem K Gupta, et al.
Urologic Oncology|July 31, 2004
Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line modelK C Balaji, Prema S Rao, David J Smith, et al.
Cancer Research|February 8, 2005
E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancerMeena Jaggi, Prema S Rao, David J Smith, et al.
Urologic Oncology|November 23, 2005
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancerTamra E Lewis, Terry D Milam, Douglas W Klingler, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biochemical and Biophysical Research Communications|July 16, 2003
Protein kinase C mu is down-regulated in androgen-independent prostate cancerMeena Jaggi, Prema S Rao, David J Smith, et al.
Biochemical and Biophysical Research Communications|October 11, 2003
Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancerPrema S Rao, Meena Jaggi, David J Smith, et al.
International Journal of Oncology|November 8, 2006
RNF2 interacts with the linker region of the human P-glycoproteinPrema S Rao, Kavita B Mallya, Kalkunte S Srivenugopal, et al.
Proteomics|May 1, 2009
RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathwaysPrema S Rao, Arun Satelli, Sheng Zhang, et al.
Oncology Reports|February 22, 2008
Varied expression and localization of multiple galectins in different cancer cell linesArun Satelli, Prema S Rao, Prem K Gupta, et al.
Urologic Oncology|July 31, 2004
Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line modelK C Balaji, Prema S Rao, David J Smith, et al.
Cancer Research|February 8, 2005
E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancerMeena Jaggi, Prema S Rao, David J Smith, et al.
Urologic Oncology|November 23, 2005
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancerTamra E Lewis, Terry D Milam, Douglas W Klingler, et al.
Pageof 2